Hanmi Pharm. Co., Ltd.
Hanmi Pharm. Co., Ltd. (KRX: 128940) is trading at ₩480,500.00, about ₹34,679 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 10.02% today. Hanmi Pharm. is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩475,000.00
Today's high
₩526,000.00
52 week low
₩302,000.00
52 week high
₩647,000.00
128940 opened at ₩526,000.00, closed previously at ₩534,000.00, and has traded between ₩302,000.00 and ₩647,000.00 over the past 52 weeks.
About
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Key statistics
Avg. volume
146.47K
Market cap
₩6.09T
P/E Ratio
25.95
Price-to-sales ratio
3.68
Enterprise value
₩6.12T
Free cash flow yield
2.20%
Debt-to-equity ratio
0.30
Return on equity
13.64%
ROIC
10.31%
Beta
0.49
Dividend yield
0.42%
Last dividend
₩2,250.00
Financial overview
Revenue
₩1.55T
Earnings per share
₩13,371.00
Free cash flow
₩127.12B
Net profit margin
13.11%
Gross margin
59.59%
EBITDA
₩322.68B
Revenue growth
3.48%
Similar securities
This is not an investment recommendation
Hanmi Pharm. for Indian investors
Hanmi Pharm. is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Hanmi Pharm. for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Hanmi Pharm.’s current yield is 0.42%.Dividend tax explained
FAQs
Can I buy Hanmi Pharm. on Paasa?
Hanmi Pharm. (128940) has been listed on the Korea Exchange since 2010, in the Drug Manufacturers - Specialty & Generic industry. Hanmi Pharm. is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Hanmi Pharm. share cost in rupees?
One Hanmi Pharm. share is ₩480,500.00 — about ₹34,679 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Hanmi Pharm. price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Hanmi Pharm. shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hanmi Pharm. price.
Does Hanmi Pharm. pay a dividend, and how is it taxed in India?
Yes. Hanmi Pharm. pays a dividend and the current yield is 0.42%; the last declared dividend was ₩2,250.00 per share, about ₹162.39. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Hanmi Pharm. shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Hanmi Pharm.?
Yes. Hanmi Pharm. is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.